Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms

Disease Markers

Volumn 26, Issue 3, 2009, Pages 119-126

  Navarro Hernández, Rosa Elena ^a   Oregon Romero, Edith ^a   Mercado, Mónica Vázquez Del ^a   Rangel Villalobos, Héctor ^a   Palafox Sánchez, Claudia Azucena ^a   Muoz Valle, José Francisco ^a,b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b NONE   (Mexico)

Author keywords

ICAM 1; Polymorphism; Rheumatoid arthritis; Soluble adhesion molecules; VCAM 1

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERCELLULAR ADHESION MOLECULE 1; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RHEUMATOID FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

EID: 68649119081     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0621     Document Type: Article

References (53)

1. D.M. Lee and M.E. Weinblatt, Rheumatoid arthritis, Lancet 358 (2001), 903-911.
2. J.B. Smith and M.K. Haynes, Rheumatoid arthritis-a molecular understanding, Ann Intern Med 136 (2002), 908-922.
3. J.J. Goronzy and C.M. Weyand, Rheumatoid arthritis, Immunol Rev 204 (2005), 55-73.
4. G.S. Firestein, Evolving concepts of rheumatoid arthritis, Nature 423 (2003), 356-361.
5. Z. Szekanecz and A.E. Koch, Mechanisms of Disease: an-giogenesis in inflammatory diseases, Nature Clinical Practice Rheumatology 3 (2007), 635-643.
6. C.M. Weyand and J.J. Goronzy, Pathogenesis of rheumatoid arthritis, Med Clin North Am 81 (1997), 29-55.
7. T. Lebedeva, M.L. Dustin and Y. Sykulev, ICAM-1 co-stimulates target cells to facilitate antigen presentation, Curr Opin Immunol 17 (2005), 251-258.
8. A. Meager, Cytokine regulation of cellular adhesion molecule expression in inflammation, Cytokine Growth Factor Rev 10 (1999), 27-39.
9. R.W. McMurray, Adhesion molecules in autoimmune disease, Semin Arthritis Rheum 25 (1996), 215-233.
10. P.P. Sfikakis and G.C. Tsokos, Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases, Clin Diagn Lab Immunol 4 (1997), 241-246.
11. A. Meager, C. Bird and A. Mire-Sluis, Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors, J Immunol Methods 191 (1996), 97-112.
12. J.D. Rioux and A.K. Abbas, Paths to understanding the genetic basis of autoimmune disease, Nature 435 (2005), 584-589.
13. J. Ermann and C.G. Fathman, Autoimmune diseases: genes, bugs and failed regulation, Nat Immunol 2 (2001), 759-761.
14. K. Wenzel, M. Ernst, K. Rohde, G. Baumann and A. Speer, DNA polymorphisms in adhesion molecule genes-a new risk factor for early atherosclerosis, Hum Genet 97 (1996), 15-20.
15. J.G. Taylor, D.C. Tang, S.A. Savage, S.F. Leitman, S.I. Heller, G.R, Serjeant, G.P. Rodgers and S.J.Chanock, Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease, Blood 100 (2002), 4303-4309.
16. P. Macchioni, L. Boiardi, B. Casali, D. Nicoli, E. Farnetti and C. Salvarani, Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis, Clin Exp Rheumatol 18 (2000), 553-558.
17. A.J. MacGregor, H. Snieder, A.S. Rigby, M. Koskenvuo, J. Kaprio, K. Aho and A.J. Silman, Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins, Arthritis Rheum 43 (2000), 30-37.
18. E.B. Lee, J.Y. Kim, E.H. Kim, J.H. Nam, K.S. Park and Y.W. Song, Intercellular adhesion molecule-1 polymorphisms in Korean patients with rheumatoid arthritis, Tissue Antigens 64-4 (2004), 473-477.
19. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum 31 (1988), 315-324.
20. C. Gorodezky, C. Alaez, M.N. Vazquez-Garcia, G. de la Rosa, E. Infante, S. Balladares, R. Toribio, E. Pérez-Luque and L. Muñoz, The genetic structure of Mexican Mestizosof different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites, Hum Immunol 62 (2001), 979-991.
21. M.H. Cardiel, M. Abello-Banfi, R. Ruiz-Mercado and D. Alarcon-Segovia, How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI), Clin Exp Rheumatol 11 (1993), 117-121.
22. M.L. Prevoo, M.A. van 't Hof, H.H. Kuper, van M.A. Leeuwen, L.B. van de Putte and P.L. van Riel, Modified disease activity scores that include twenty-eight-joint counts, Development and validation in a prospectivelongitudinalstudy of patients with rheumatoid arthritis, Arthritis Rheum 38 (1995), 44-48.
23. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res 16 (1988), 1215.
24. M.I. Cybulsky, J.W. Fries, A.J. Williams, P. Sultan, R. Eddy, M. Byers, T. Shows, M.A. Gimbrone, Jr. and T. Collins, Gene structure, chromosomal location, and basis for alternative mR-NA splicing of the human VCAM1 gene, Proc Natl Acad Sci USA 88 (1991), 7859-7863.
25. M.M. Amoli, E. Shelley, D.L. Mattey, C. Garcia-Porrua, W. Thomson, A.H. Hajeer, W.E. Ollier and M.A. Gonzalez-Gay, Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis, J Rheumatol 28 (2001), 1600-1604.
26. D.K. Vora, C.L. Rosenbloom, A.L. Beaudet et al., Polymorphisms and linkage analysis for ICAM1 and the selectin gene cluster, Genomics 21-3 (1994), 473-477.
27. A.J. Littler, C.D. Buckley, P.Wordsworth, I.Collins, J. Martinson and D.L. Simmons, A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis, Br J Rheumatol 36 (1997), 164-169.
28. Y.M. El-Miedany, S.Ashour, H.Moustafa, and IHAB Ahmed, Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy, J Rheumatol 29 (2002), 57-61.
29. B.J. Bloom, L.C. Miller, L.B. Tucker, J.G. Schaller and P.R. Blier, Soluble adhesion molecules in juvenile rheumatoid arthritis, J Rheumatol 26 (1999), 2044-2048.
30. P.Dolezalova, P.Telekesova, D.Nemcova and J.Hoza, Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations, Clin Exp Rheumatol 20 (2002), 249-254.
31. P.A. Klimiuk, S. Sierakowski, R. Latosiewicz, J.P. Cylwik, B. Cylwik, J. Skowronski and J. Chwiecko, Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis, Ann Rheum Dis 61 (2002), 804-809.
32. C.Y. Chen, C.H. Tsao, L.S. Ou, M.H. Yang, M.L. Kuo and J.L. Huang, Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages, Ann Rheum Dis 61 (2002), 167-170.
33. K. Degitz, L. Lian-Jie and S. Wright Caughman, Cloning and characterization of the 5'-transcriptional regulatory region of the human intercellular adhesion molecule 1 gene, The J Biol Chem 266-21 (1991), 14024-14030.
34. D.H. Verity, R.W. Vaughan, E. Kondeatis, W. Madanat, H. Zureikat, F. Fayyad, J.E. Marr, C.A. Kanawati, G.R. Wallace and M.R. Stanford, Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease, Eur J Immunogenet 27 (2000), 73-76.
35. P. Vigano, M. Infantino, D. Lattuada, R. Lauletta, E. Pon-ti, E. Somigliana, M. Vignali and A.M. DiBlasio, Intercellular adhesion molecule-1 (ICAM1) gene polymorphisms in endometriosis, Mol Hum Reprod 9 (2003), 47-52.
36. M. Yamashita, S. Yoshida, S. Kennedy, N. Ohara, S. Mo-toyama and T. Maruo, Association study of endometriosis and intercellular adhesion molecule-1 (ICAM1) gene polymorphisms in a Japanese population, J Soc Gynecol Investig 12 (2005), 267-271.
37. A. Ponthieux, D. Lambert, B. Herbeth, S. Droesch, M. Pfis-ter and S. Visvikis, Association between Gly241Arg ICAM1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort, Eur J Hum Genet 11 (2003), 679-686.
38. S. Borozdenkova, J. Smith, S. Marshall, M. Yacoub and M. Rose, Identification of ICAM1 vpolymorphism thatisassociated with protection from transplant associated vasculopathy after cardiac transplantation, Hum Immunol 62 (2001), 247-255.
39. A. Kretowski, N. Wawrusiewicz, K. Mironczuk, J. Mysliwiec, M. Kretowska and I. Kinalska, Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease, J Clin Endocrinol Metab 88 (2003), 4945-4949.
40. C. Salvarani, B. Casali, L. Boiardi, A. Ranzi, P. Macchioni, D. Nicoli, E. Farnetti, M. Brini and I. Portioli, Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity, J Rheumatol 27 (2000), 1215-1221.
41. A.J. McLaren, S.E. Marshall, N.A. Haldar, C.G. Mullighan, S.V. Fuggle, P.J. Morris and K.I. Welsh, Adhesion molecule polymorphisms in chronic renal allograft failure, Kidney Int 55 (1999), 1977-1982.
42. Y.K. Kim, C.W. Pyo, S.S. Hur, T.Y. Kim and T.G. Kim, No associations of CTLA-4 and ICAM1 polymorphisms with psoriasis in the Korean population, J Dermatol Sci 33 (2003), 75-77.
43. M.M. Amoli, W.E. Ollier, M. Lueiro, M.L. Fernandez, C. Garcia-Porrua and M.A. Gonzalez-Gay, Lack of association between ICAM-1 gene polymorphisms and biopsy-proven erythema nodosum, J Rheumatol 31 (2004), 403-405.
44. M.W. Quasney, G.W. Waterer, M.K. Dahmer, D. Turner, Q. Zhang, R.M. Cantor and R.G. Wunderink, Intracellular adhesion molecule Gly241Arg polymorphism has no impact on ARDS or septic shock in community-acquired pneumonia, Chest 121 (2002), 85S-86S.
45. X. Yang, S.N. Cullen, J.H. Li, R.W. Chapman and D.P. Jewell, Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1, J Hepatol 40 (2004), 375-379.
46. M.M. Amoli, E. Shelley, D.L. Mattey, C. Garcia-Porrua, W. Thomson, A.H. Hajeer, W.E. Ollier and M.A. Gonzalez-Gay, Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica, J Rheumatol 29 (2002), 502-504.
47. E.G. Corona-Sanchez, L. Gonzalez-Lopez, J.F. Muñoz-Valle, M. Vazquez-Del Mercado, M.A. Lopez-Olivo, E.A. Aguilar-Chavez, M. Salazar-Paramo, C. Loaiza-Cardenas, E. Oregon-Romero, R.E. Navarro-Hernandez and J.I. Gamez-Nava, Circulating E-selectin and tumor necrosis factor-alpha in extraar-ticular involvement and joint disease activity in rheumatoid arthritis, Rheumatol Int 29(3) (2009), 281-286.
48. D. Elewaut, F. De Keyser, N. De Wever, D. Baeten, N. Van Damme, G. Verbruggen, C. Cuvelier and E.M. Veys, A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers, Ann Rheum Dis 57 (1998), 480-486.
49. J.C.W. Edwards, L.S. Wilkinson and A.A. Pitsillides, Palisading cells of rheumatoid nodules: comparison with synovial intimal cells, Annals of the Rheumatic Diseases 52 (1993), 801-805.
50. V. García-Patos, Semin Cutan Med Surg 26(2) (2007), 100-107.
51. C. Turesson and E.L. Matteson, Vasculitis in rheumatoid arthritis, Current Op in Rheum 21 (2009), 35-40.
52. I. Ghersetich and T. Lotti, Cellular steps in the pathogenesis of cutaneous necrotizing vasculitis, Int Angiol 14(2) (1995), 107-112.
53. J.R. Bradley, C.M. Lockwood and S. Thiru, Endothelial cell activation in patients with systemic vasculitis, QJM 87(12) (1994), 741-745.